UK: A recent consensus statement from leading UK medical organizations—including the Association of Anaesthetists, the ...

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide ... and claiming that the prices of GLP-1 drugs for weight loss are five ...

People who take weight-loss drugs based on GLP-1 receptor agonists seem to have ... and Eli Lilly's tirzepatide for diabetes and obesity to 'usual care' – in other words other standard drug ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

Byline: Hank Popeil In the ever-evolving landscape of healthcare, groundbreaking innovations are not merely celebrated for their scientific ingenuity but for their potential to radically improve human ...

Viking Therapeutics (VKTX) surges 10% on renewed takeover speculation, with Pfizer rumored as a potential buyer.

At the end of the day, weight loss options, like any other health-related decisions, are very personal and must be made on a ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Lilly's retatrutide shows remarkable weight loss in trials but raises concerns with side effects possibly linked to the drug like nausea and kidney stones. Read more here.